Amount Raised
$47 Million
Round Type
series c
BeijingDescription
Chinese pharmaceutical firm Jiangsu Atom Bioscience & Pharmaceutical has raised over 300 million yuan ($47.2 million) in a Series C round of financing led by Beijing-based Kingray Capital, a state-backed firm that invests in Chinese yuan.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech